The uptake mechanism of FITC-labeled albumin (FITC-albumin) was examined in human alveolar epithelial cell line A549. FITC-albumin uptake by A549 cells was time-and temperaturedependent, and was markedly suppressed at 4°C compared with that at 37°C. The uptake was saturable, and was mediated by a high-affinity, low-capacity system and by a low-affinity, high-capacity system. In the following experiments, we focused on the low-affinity system. FITC-albumin uptake was markedly inhibited by metabolic inhibitors and by a vacuolar H + -ATPase, bafilomycin A 1 . The uptake was inhibited by clathrinmediated endocytosis inhibitors (phenylarsine oxide and chlorpromazine). Potassium depletion and hypertonicity that inhibit clathrin-mediated endocytosis also decreased FITC-albumin uptake. On the other hand, caveolae-mediated endocytosis inhibitors (indomethacin and nystatin) did not affect FITC-albumin uptake. In addition, FITC-albumin uptake was inhibited by macropinocytosis inhibitors such as 5-(N-ethyl-Nisopropyl) amiloride. These results suggest that the low-affinity system of FITC-albumin uptake is mediated by endocytosis in A549 cells, predominantly via a clathrin-mediated pathway. Macropinocytosis, but not caveolae-mediated endocytosis, may also be involved. Considering our previous findings, albumin may be transported by a similar mechanism and/or pathway in rat and human alveolar epithelial cells.
Introduction
Alveolar lining fluid contains various proteins such as albumin, immunoglobulin G ¤IgG¥, IgA, transferrin, and ceruloplasmin that are important for physiological, antioxidant, and mucosal defense functions. 1®4¥ The concentration of albumin is normally about 5 mg/mL in alveolar fluid and is much lower than that in the plasma ¤40 mg/mL¥. However, the concentration increases to 40®65% of the plasma level in hydrostatic pulmonary edema and to 75® 95% in lung injury pulmonary edema. Alveolar clearance of proteins is a critical process in recovery from pulmonary edema as well as in maintaining the normal alveolar milieu. The inability to clear excess proteins from the alveolar space results in poor prognosis in patients suffering from pulmonary edema, because of inefficient clearance of edema fluid due to increased oncotic pressure.
2,3,5¥ Therefore, understanding the mechanisms of protein transport in alveolar epithelial cells would be important for the development of approaches to facilitate recovery from lung injury accompanied with edema. The alveolar region of the lung is lined with a continuous epithelium comprising two major types of epithelial cells, type I and type II. 1¥ Alveolar type I epithelial cells have a squamous morphology, cover approximately 90®95% of the alveolar surface area, and are essential for normal gas exchange. On the other hand, type II cells are cuboidal epithelial cells, cover about 5®10% of the surface area, have a characteristic intracellular structure called the lamellar body, and play various important roles including surfactant production and secretion. In addition, type II cells serve as progenitor cells of type I cells, and transdifferentiate into type I cells to repair the epithelium when it is injured.
We have previously reported the culture conditions that are suitable for the study of the characteristics of type II and type I alveolar epithelial cells in primary culture, and using these primary cultured alveolar epithelial cells isolated from rat lung, the characteristics of albumin uptake were evaluated and compared between type II and type I cells. 7¥ Interestingly, we found that the uptake clearance of albumin was much greater in type II cells than in type I cells, and the temperature-sensitive uptake of FITC-albumin per cell was estimated to be 2.4-fold higher in type II cells than that in type I-like cells. 7¥ Therefore, assuming that the number of type II cells is about 1.5-fold of that of type I cells, the contribution of type II cells to total albumin uptake was estimated to be more than 75%, although the alveolar surface area covered by type II cells is only 5®10%, as described above. We have also examined the transport characteristics of albumin using an alveolar epithelial cell line, RLE-6TN.
7,8¥ RLE-6TN is a cell line established from normal rat lung, and has several characteristics similar to alveolar type II epithelial cells such as the expression of cytokeratin 19.
9,10¥
On the other hand, there is little information concerning the mechanism underlying albumin uptake by human alveolar epithelial cells. A549 is an epithelial cell line derived from human lung carcinoma, 11¥ and has been widely used as an in vitro model of human alveolar type II epithelial cells for biochemical and toxicological studies.
12,13¥
The cells form confluent monolayers with morphological and functional characteristics similar to alveolar type II epithelial cells, and Foster et al. 14¥ indicated that A549 would be a useful in vitro model to study the transport of macromolecules such as transferrin as well as to study drug metabolism. The purpose of this study is to characterize the uptake of albumin in A549 cells, and to compare the characteristics with those observed in RLE-6TN cells and in primary cultured rat alveolar type II epithelial cells.
Materials and Methods

Materials:
Dulbeccoös modified Eagleös medium ¤DMEM¥, trypsin-EDTA, and penicillin-streptomycin were purchased from Invitrogen ¤Grand Island, NY, USA¥. Fetal bovine serum ¤FBS¥ was purchased from Daiichi Pure Chemicals ¤Tokyo, Japan¥. FITC-labeled bovine serum albumin ¤FITC-albumin¥, phenylarsine oxide, bafilomycin A 1 , indomethacin, nystatin, 5-¤N-ethyl-N-isopropyl¥ amiloride, and cytochalasin D were purchased from Sigma-Aldrich ¤St. Louis, MO, USA¥. Chlorpromazine and 2,4-dinitrophenol were purchased from Nacalai Tesque ¤Kyoto, Japan¥. 2-Deoxy-D-glucose was purchased from Kanto Chemical Co. ¤Tokyo, Japan¥ and sodium azide from Katayama Chem. ¤Tokyo, Japan¥. All other chemicals used for the experiments were of the highest purity commercially available.
Cell culture: A549 cells were provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. Cells were cultured in DMEM containing 10% FBS, 100 IU/mL penicillin, and 100 mg/mL streptomycin, in an atmosphere of 5% CO 2 ®95% air at 37ôC, and subcultured every 7 days using 0.25% trypsin and 1 mM EDTA. A549 cells were used between passages 94 and 114. Fresh medium was provided every 2 or 3 days, and the cells were used for the experiments on the sixth day after seeding.
Uptake studies: Uptake experiments were performed as described previously.
8¥ A549 cells grown on 35-mm culture dishes were used. After removal of the culture medium, each dish was washed and preincubated with phosphate-buffered saline ¤PBS buffer: 137 mM NaCl, 3 mM KCl, 8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 0.1 mM CaCl 2 , and 0.5 mM MgCl 2 , pH 7.4¥ supplemented with 5 mM Dglucose ¤PBS-G buffer¥ at 37ôC for 10 min. Then, PBS-G buffer containing FITC-albumin ¤20 mg/mL¥ was added to each dish, and the cells were incubated at 37ôC or 4ôC for a specified period. For inhibition studies, A549 cells were preincubated with PBS or PBS-G buffer in the absence or presence of the inhibitor as follows: 1 mM 2,4-dinitrophenol for 10 min in PBS buffer, 10 mM sodium azide plus 5 mM 2-deoxy-D-glucose for 10 min in PBS buffer, 100 nM bafilomycin A 1 for 30 min in PBS-G buffer containing 0.5% dimethyl sulfoxide ¤DMSO¥, phenylarsine oxide ¤5®30 µM¥ for 10 min in PBS-G buffer containing 0.5% DMSO, chlorpromazine ¤35®140 µM¥ for 10 min in PBS-G buffer, indomethacin ¤100®300 µM¥ for 10 min in PBS-G buffer, nystatin ¤15®50 µM¥ for 10 min in PBS-G buffer containing 0.5% DMSO, cytochalasin D ¤3®20 µM¥ for 15 min in PBS-G buffer containing 0.5% DMSO, and 5-¤N-ethyl-Nisopropyl¥ amiloride ¤25®75 µM¥ for 10 min in PBS-G buffer containing 0.5% DMSO. The same vehicles were used for each control experiment. After removal of the preincubation buffer, the cells were incubated with 1 mL of the uptake buffer containing FITC-albumin in the absence or presence of the inhibitors at 37ôC or 4ôC for 60 min. Bafilomycin A 1 and phenylarsine oxide were used only in the preincubation buffer.
To evaluate the effects of extracellular pH on albumin uptake, A549 cells were incubated with FITC-albumin at pH 6.0, 6.5, 7.0, and 7.4 for 60 min at 37ôC or 4ôC. The effects of potassium depletion and hypertonicity on albumin uptake in A549 cells were examined as reported by Tagawa et al. 8¥ The control buffer used for potassium depletion and hypertonicity experiments consisted of 140 mM NaCl, 10 mM KCl, 20 mM HEPES, 1 mM CaCl 2 , 1 mM MgCl 2 , and 1 mg/mL D-glucose ¤pH 7.4¥. For the hypertonicity experiment, 450 mM sucrose was added to the control buffer, and for the potassium depletion experiment, KCl was omitted from the control buffer. Uptake of FITCalbumin in these treated or control A549 cells was examined as described above.
At the end of the incubation, the uptake buffer was aspirated and the cells were washed rapidly three times with 1 mL of ice-cold PBS buffer. The cells were scraped with a rubber policeman into 0.75 mL of ice-cold PBS buffer and the dishes were rinsed again with 0.75 mL of ice-cold PBS buffer to improve the recovery of the cells. The cells were further washed by centrifugation at 4ôC for 3 min at 9,838 ' g twice. After the supernatant was aspirated, the pellet was solubilized in 1.2 mL of 0.1% Triton X-100 in PBS buffer without CaCl 2 and MgCl 2 at room temperature for 30 min, and centrifuged for 3 min at 5,600 ' g. The supernatant was used for fluorescence and protein assays.
Other analytical methods: The amount of FITCalbumin taken up by A549 cells was measured using a Hitachi fluorescence spectrophotometer F-2700 ¤Tokyo, Japan¥ at an excitation wavelength of 500 nm and an emission wavelength of 520 nm. Protein was determined by the Lowry method with bovine serum albumin as the standard.
Statistical analysis: Data are expressed as means + S.E.M. Statistical analysis was performed by Studentös t-test or one-way ANOVA followed by Tukeyös test for multiple comparisons. The level of significance was set at p g 0.01.
Results
Time-and temperature-dependence of FITCalbumin uptake by A549 cells: We first examined the time-and temperature-dependence of FITC-albumin uptake by A549 cells ¤Fig. 1¥. The uptake of FITC-albumin increased linearly with time for up to 60 min at 37ôC. At 4ôC, the uptake was much lower, and it was less than 20% of that at 37ôC at 60 min. In addition, the apparent uptake of FITC-albumin at 4ôC was fairly constant throughout the incubation period. The uptake of FITC-albumin ¤20 mg/mL¥ at 37ôC was compared with that of FD-70 ¤20 mg/mL¥, a fluid-phase endocytosis marker having a similar molecular size with albumin. FITC-albumin uptake was more than 200-fold higher ¤182.4 + 4.1 µg/mg protein/60 min; mean + S.E.M. of 3 determinations¥ than that of FD-70 ¤0.87 + 0.01 µg/mg protein/60 min; mean + S.E.M. of 3 determinations¥.
Concentration-dependence of FITC-albumin uptake by A549 cells: Figure 2 shows the concentrationdependence of FITC-albumin uptake by A549 cells. The uptake was saturable ¤Fig. 2¥, and as evidenced by the Eadie®Hofstee plot ¤inset¥; the uptake was mediated by highand low-affinity transport systems. The K m and maximum uptake rate ¤V max ¥ for the high-affinity system were calculated to be 1.3 mg/mL and 12.7 µg/mg protein/60 min, and those for the low-affinity system were 45.6 mg/mL and 330.9 µg/mg protein/60 min, respectively. In the following experiments, we focused on the low-affinity system, which would be more important for the alveolar clearance of albumin under physiological and pathophysiological conditions.
Effect of metabolic inhibitors and a vacuolar H ¦ -ATPase inhibitor on FITC-albumin uptake by A549 cells: We next examined the effects of metabolic inhibitors on FITC-albumin uptake. Pretreatment of A549 cells with either 2,4-dinitrophenol or sodium azide plus 2-deoxy-Dglucose significantly inhibited FITC-albumin uptake to 8.6% and 16% of control, respectively ¤Fig. 3A¥. In addition, FITC-albumin uptake was inhibited by pretreatment of the cells with bafilomycin A 1 , an inhibitor of vacuolar H ¦ -ATPase ¤Fig. 3B¥.
Effect of extracellular pH on FITC-albumin uptake by A549 cells: The effect of extracellular pH on FITC-albumin uptake was examined ¤Fig. 4¥. The uptake at pH 7.0 was almost the same as that at pH 7.4, while at lower pHs ¤6.5 and 6.0¥, the uptake decreased with the decrease in pH. At pH 6.0, FITC-albumin uptake was about 40% of that at pH 7.4.
Pathway¤s¥ of FITC-albumin endocytosis in A549 cells: In order to determine the pathway of FITC-albumin endocytosis in A549 cells, the effects of various endocytosis inhibitors were examined. First, we examined the role of clathrin-mediated endocytosis by using its inhibitors, phenylarsine oxide and chlorpromazine. The uptake of FITC-albumin was inhibited by these inhibitors in a concentration-dependent fashion ¤Figs. 5A and 5B¥. The inhibitory effects of these inhibitors were potent, and with 30 µM phenylarsine oxide, the uptake was decreased to less than 10% of control. Furthermore, the effects of potassium depletion and hypertonicity on FITC-albumin uptake, the conditions known to inhibit clathrin-mediated endocytosis, were examined. As shown in Figure 5C , both potassium depletion and hypertonicity markedly inhibited FITCalbumin uptake by A549 cells.
Next, the role of caveolae-mediated endocytosis was examined. For this purpose, indomethacin and nystatin, inhibitors of caveolae-mediated endocytosis, were used. However, as shown in Figure 6 , indomethacin and nystatin did not affect FITC-albumin uptake by A549 cells with concentrations up to 300 µM and 50 µM, respectively.
Finally, the role of macropinocytosis, a process accompanied by the formation of large, irregular primary endocytic vesicles, was examined in A549 cells using compounds known to inhibit macropinocytosis. The uptake of FITC-albumin was inhibited by cytochalasin D, an inhibitor of F-actin elongation involved in macropinocytosis, in a concentration-dependent manner, and with 20 µM of cytochalasin D, the uptake was inhibited to about 30% of control ¤Fig. 7A¥. FITC-albumin uptake was also inhibited by 5-¤N-ethyl-N-isopropyl¥ amiloride, a more potent analogue of amiloride which blocks Na ¦ /H ¦ exchange and macropinocytosis ¤Fig. 7B¥. 4 . Effect of extracellular pH on FITC-albumin uptake by A549 cells A549 cells were incubated with FITC-albumin (20 mg/mL) at various pHs for 60 min, and the specific uptake was measured. Each data represents the mean + S.E.M. of 3 determinations. **p g 0.01; significantly different from the value at pH 6.0.
Fig. 5. Effect of clathrin-mediated endocytosis inhibitors on FITC-albumin uptake by A549 cells
The cells were treated with various concentrations of phenylarsine oxide (A) or chlorpromazine (B) as described in Materials and Methods. (C) Experimental conditions to induce potassium depletion and hypertonicity were described in Materials and Methods. Specific uptake of FITC-albumin (20 mg/mL) for 60 min was measured. Each data represents the mean + S.E.M. of 3 determinations. **p g 0.01; significantly different from each control.
Discussion
In the present study, the characteristics of albumin uptake were examined in A549 cells using FITC-labeled albumin. Boutoille et al. 15¥ examined endothelial permeability of FITC-albumin as a marker for assessment, and compared the permeability with that of 125 I-labeled albumin. They found a very strong correlation between calculated permeability values obtained with FITC-albumin and 125 Ilabeled albumin, and concluded that FITC-albumin can be a useful probe for assessment of the endothelial permeability of albumin. FITC-albumin uptake by A549 cells at 37ôC was time-dependent, and increased linearly up to 60 min. On the other hand, the uptake at 4ôC was much lower than that at 37ôC, and time-dependence was hardly observed ¤Fig. 1¥. Thus, the apparent uptake observed at 4ôC may reflect the surface binding of FITC-albumin in A549 cells. The specific ¤temperature-sensitive¥ uptake of FITC-albumin was saturable, and the analysis with Eadie®Hofstee plots indicated the involvement of high-and low-affinity transport systems ¤Fig. 2¥. The K m value for each transport system was 1.3 mg/mL and 45.6 mg/mL, respectively. High-and lowaffinity transport systems for albumin uptake were also observed in RLE-6TN cells 10¥ and in rat alveolar type II epithelial cells in primary culture ¤unpublished observation¥. Therefore, involvement of two transport systems with different affinities ¤or a single transport system consisting of two binding sites having different affinities to albumin¥ may be a common feature for albumin uptake in human and rat alveolar type II epithelial cells. As described in the Introduction, the concentration of albumin in alveolar fluid is normally about 5 mg/mL and is higher in pulmonary edema. When we consider the kinetic parameters of FITC-albumin uptake in A549 cells, the low-affinity transport system would be more important than the high-affinity transport system in the clearance of albumin under physiological and pathophysiological conditions. Therefore, in the following experiments, we focused on the low-affinity transport system of FITC-albumin in A549 cells. For this purpose, FITC-albumin at a concentration of 20 mg/mL was used for uptake experiments; the contribution of the low-affinity transport system was calculated to be about 90% at this concentration.
The uptake of FITC-albumin by A549 cells was inhibited by metabolic inhibitors ¤2,4-dinitrophenol and sodium azide plus 2-deoxy-D-glucose¥ and by bafilomycin A 1 ¤Figs. 3A and 3B¥. Bafilomycin A 1 is a potent inhibitor of vacuolar H ¦ -ATPase that localizes in the endosomal membrane and is responsible for lowering the endosomal pH. The acidification of endosomal pH is an essential process for the dissociation of ligands and receptors after receptormediated endocytosis. 16¥ Inhibition of vacuolar H ¦ -ATPase, therefore, results in a decrease in receptor-mediated endocytosis.
17,18¥ In addition, the uptake of FITC-albumin by A549 cells was more than 200-fold higher than that of FD-70. FD-70 has a similar molecular size to that of FITC-albumin, but should be taken up by the fluid phase endocytosis. 19¥ These results suggest that FITCalbumin is taken up efficiently by A549 cells in an energydependent manner; most likely by a receptor-mediated endocytosis.
As described above, pH would affect the ligand binding to its receptor in the endosomes. For example, following binding of a ligand to the asialoglycoprotein receptor at the cell surface, the receptor-ligand complex is endocytosed via clathrin-coated pits and directed to endosomes. In the endosomes, the ligand-receptor complex dissociates under acidic pHs, and the receptor recycles to the cell surface. 20¥ Wragg and Drickamer 21¥ reported that, at physiological Ca 2¦ concentrations, the midpoint for ligand release from the Ca
2¦
-dependent carbohydrate-recognition domain of hepatic asialoglycoprotein receptor is pH 7.1, and His256, Asp266, and Arg270 residues of the domain should be important in conferring appropriate pH dependence of the ligand binding. Thus, an extracellular pH may also directly or indirectly affect the overall FITC-albumin uptake process. As shown in Figure 4 , FITC-albumin uptake was reduced at an acidic pH, which may further support the involvement of a putative receptor and its recycling during FITC-albumin uptake by A549 cells.
Pinocytosis can be classified into several pathways such as clathrin-mediated endocytosis, caveolae-mediated endocytosis, clathrin-and caveolae-independent pathways, and macropinocytosis. Therefore, we next examined the endocytic pathway¤s¥ for FITC-albumin uptake by A549 cells. The uptake of FITC-albumin by A549 cells was inhibited by phenylarsine oxide and chlorpromazine, inhibitors of clathrin-mediated endocytosis, in a concentration-dependent manner ¤Figs. 5A and 5B¥. Phenylarsine oxide inhibits clathrin-mediated endocytosis by reacting with vicinal sulfhydryls to form stable ring structures, 22¥ and chlorpromazine inhibits the process by inducing the loss of coated pits from the cell surface by interacting with AP-2 binding to membranes.
23¥ FITC-albumin uptake was also inhibited by potassium depletion and hypertonicity in A549 cells ¤Fig. 5C¥. These treatments are known to inhibit clathrin-mediated endocytosis by inducing the disappearance of clathrin-coated pits from the plasma membrane.
24,25¥ These results strongly suggest that clathrin-mediated endocytosis is involved in FITC-albumin uptake by A549 cells.
On the other hand, FITC-albumin uptake was not affected by indomethacin or nystatin, inhibitors of caveolae-mediated endocytosis ¤Fig. 6¥. Caveolae, which are flask-shaped invaginations of the plasma membrane, are cholesteroland sphingolipid-rich microdomains. The shape and structure of caveolae are conferred by caveolin, a dimeric protein that binds cholesterol.
26,27¥ Indomethacin inhibits caveolaemediated endocytosis by inhibiting the internalization of caveolae and the return of plasmalemmal vesicles to the cell surface, and nystatin inhibits the process by interacting with cholesterol in the plasma membrane.
22,28®30¥ Rejman et al.
31¥
reported that gene transfer mediated by cationic polymer/ DNA complexes ¤polyplexes¥ was completely inhibited by caveolae-mediated endocytosis inhibitors such as filipin, an inhibitor having a similar mechanism to nystatin, in A549 cells. Therefore, caveolae-mediated endocytosis would function in A549 cells, and insensitivity to caveolae-mediated endocytosis inhibitors observed in this study would indicate that the process is not involved in FITC-albumin uptake by A549 cells. The inhibition of FITC-albumin uptake by clathrin-mediated endocytosis inhibitors, but not by caveolae-mediated endocytosis inhibitors, was also observed in RLE-6TN cells and in primary cultured rat alveolar type II epithelial cells.
7,10¥
Macropinocytosis is one of the endocytic processes that is accompanied by cell surface ruffling, and is characteristically different from other endocytic processes. 32¥ In human dendric cells, it was shown that amiloride inhibited FITCalbumin uptake via macropinocytosis stimulated by IL-10. 33¥ Therefore, the role of macropinocytosis in FITC-albumin uptake by A549 cells was examined. As shown in Figure 7 , the uptake of FITC-albumin was inhibited by cytochalasin D and 5-¤N-ethyl-N-isopropyl¥ amiloride in a concentration-dependent manner. These compounds inhibit macropinocytosis by inhibiting F-actin polymerization and by lowering cytoplasmic pH, respectively. 34,35¥ Thus, macropinocytosis may also be involved in FITC-albumin uptake by A549 cells. The possible involvement of macropinocytosis was also suggested in RLE-6TN cells. 8¥ However, if we assume that clathrin-mediated endocytosis and macropinocytosis are independently involved in FITC-albumin uptake, the inhibitory effect by each inhibitor may be too potent ¤Figs. 5 and 7¥. It may be due to the possible inhibition of clathrin-mediated endocytosis by macropinocytosis inhibitors employed. In fact, 5-¤N-ethyl-N-isopropyl¥ amiloride is reported to inhibit clathrin-mediated uptake of albumin in the kidney cells. 35¥ In addition, F-actin may play an important role not only in macropinocytosis but also in clathrin-mediated endocytosis.
36,37¥ Therefore, further studies are needed to clarify the involvement of macropinocytosis and its contribution to FITC-albumin uptake by A549 cells.
At this moment, only limited information is available concerning albumin transport in human alveolar epithelial cells. Using human alveolar epithelial cell monolayers in primary culture, Bur et al. 38¥ showed that albumin transport across the monolayers was strongly direction-dependent, and apical-to-basal permeability was much higher than in the basal-to-apical direction. Though the precise mechanisms underlying this directional transport have not been elucidated, our results may indicate that receptor-and clathrin-mediated endocytosis in the apical uptake of albumin, a first step of transcytosis, is important for the directional transport of albumin across alveolar epithelial cell monolayers.
In conclusion, present results suggest that the low-affinity system of FITC-albumin uptake is mediated by endocytosis in A549 cells, predominantly via the clathrin-mediated pathway. Macropinocytosis, but not caveolae-mediated endocytosis, may also be involved. These characteristics of FITC-albumin uptake in A549 cells were similar to those observed in RLE-6TN cells and in primary cultured rat alveolar type II epithelial cells. Therefore, albumin may be transported by a similar mechanism and/or pathway in rat and human alveolar epithelial cells. Identification of albumin receptor¤s¥ is a very important challenge to further clarify the molecular mechanisms of albumin transport in alveolar epithelial cells.
